Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-04

Study Completion Date

2018-12-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will assess the efficacy and tolerability of two topical regimens (containing cosmetic human fibroblast-derived, physiologically-balanced growth factor combination products (HULK and TNS Essential Serum)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Assess the Cosmetic Changes in the Facial Skin After Use of a Topical Retinoid Product in Participants With Moderate to Severe Photodamage

NCT03302559

Skin Care

COMPLETED NA

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

NCT05300542

Erythema Sun Damaged Skin Skin Inflammation

COMPLETED NA

Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

NCT00834210

Acne Vulgaris

COMPLETED PHASE4

Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage

NCT02139618

Facial Photodamage

COMPLETED PHASE2

A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne

NCT03124381

Acne Vulgaris

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Photodamage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group #1

Subject in Treatment group 1 will apply the following products in the morning and evening.

1. SkinMedica Facial Cleanser
2. Hulk (cosmetic investigational)
3. Marvel AM (cosmetic investigational)
4. Marvel PM (cosmetic investigational)
5. SkinMedica HA5 Rejuvenating Hydrator
6. SkinMedica Rejuvenative Moisturizer
7. SkinMedica Essential Defense Mineral Shield SPF 35 Sunscreen

Group Type EXPERIMENTAL

on-label facial injection

Intervention Type OTHER

Assessing if adding SkinMedica's cosmetic topical skincare regimens improves the appearance of the skin and the subject's experience, when used after pre-elected on-label facial injection

Treatment group #2

Subject in Treatment group 2 will apply the following products in the morning and evening.

1. SkinMedica Facial Cleanser
2. SkinMedica TNS Essential Serum
3. Marvel AM (cosmetic investigational)
4. Marvel PM (cosmetic investigational)
5. SkinMedica HA5 Rejuvenating Hydrator
6. SkinMedica Rejuvenative Moisturizer
7. SkinMedica Essential Defense Mineral Shield SPF 35 Sunscreen

Group Type EXPERIMENTAL

on-label facial injection

Intervention Type OTHER

Assessing if adding SkinMedica's cosmetic topical skincare regimens improves the appearance of the skin and the subject's experience, when used after pre-elected on-label facial injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

on-label facial injection

Assessing if adding SkinMedica's cosmetic topical skincare regimens improves the appearance of the skin and the subject's experience, when used after pre-elected on-label facial injection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female subjects aged 30 years and older with Fitzpatrick skin type I-VI
* Pre-elected to receive on-label facial injection(s) (i.e. neuromodulator injection and/or filler injections)
* Experienced injection patients defined as having received at least 1 facial injection in the past 2 years.
* Current users of non-physician-dispensed brand skin care products (i.e. only using products that are available at drugstores or department stores
* Good general health and free of any disease state or physical condition (e.g. psoriasis, rosacea, scars, tattoos etc.)
* Willingness to have exams and digital photos performed on the face.
* Willingness to cooperate and participate by following study requirements (including using the provided test products) for the duration of the study and to report any adverse event symptoms or reactions immediately.
* Willingness to discontinue use of their current skincare products starting at their Week 4 visit in this study.
* Willingness to not use any other products, including self-tanners, on their face for the duration of the study other than make-up with an established tolerance of at least 1 month.
* Willingness to withhold all facial treatments during the course of the study including microdermabrasion, peels, facials, laser treatments and tightening treatments.
* .Willingness to avoid as much as possible, direct and prolonged sun exposure for the duration of the study (including tanning beds), especially from 10 AM to 2 PM. Subjects are asked to wear protective clothing prior to and during exposure.
* If of child-bearing potential, willing to use an acceptable method of contraception throughout the study. Acceptable methods of birth

Exclusion Criteria

* Who are nursing, pregnant, or planning to become pregnant during the study according to subject self-report.
* Individuals with active symptoms of allergy, cold sore or warts, active psoriasis or eczema, rosacea, sunburn, open wounds, neurotic excoriations, excessive scarring, tattoos, or other skin conditions in the test areas that would interfere with the assessments of this study.
* Uncontrolled disease such as diabetes, hypertension, hyper or hypo-thyroidism, active hepatitis, immune deficiency, or autoimmune.
* Individuals who have a pre-existing or dormant dermatologic condition (e.g., psoriasis, atopic dermatitis, rosacea, skin cancer, etc.)
* Individuals who require electrolysis, waxing, or use depilatories on the face during conduct of the study.
* Individuals with any planned surgeries and/or invasive medical procedures during the course of the study
* Individuals who are currently participating in any other facial usage study or have participated in any clinical trial within 4 weeks prior to inclusion of the study.
* Subjects currently on or planning to participate on any type of research study at another facility or a doctor's office during this study.

Minimum Eligible Age

30 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No